Metformin, pioglitazone and gout risk

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacoepidemiology and drug safety 2022-10, Vol.31 (10), p.1127-1128
Hauptverfasser:	Liao, Kuan‐Fu, Hwang, Bing‐Fang, Kuo, Yu‐Hung, Liu, Chiu‐Shong, Lai, Shih‐Wei
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidiabetics Gout Metformin Pioglitazone
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	1128
container_issue	10
container_start_page	1127
container_title	Pharmacoepidemiology and drug safety
container_volume	31
creator	Liao, Kuan‐Fu Hwang, Bing‐Fang Kuo, Yu‐Hung Liu, Chiu‐Shong Lai, Shih‐Wei
description
doi_str_mv	10.1002/pds.5516
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2698633728</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2711635065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3266-524c3b955adb8060f72a47303e01a35d74d559289a61258a7bea00aa8568cc773</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMoOKfgTyiI4IWdJ0lP0lzK_ISJgnodsjYdmV1TkxaZv97OCYLg1XnhPLy8PIQcU5hQAHbRlnGCSMUOGVFQKqWIcneTkac5CrVPDmJcAgw_lY3I6YPtKh9WrjlPWucXtevMp29sYpoyWfi-S4KLb4dkrzJ1tEc_d0xeb65fpnfp7PH2fno5SwvOhEiRZQWfK0RTznMQUElmMsmBW6CGYymzElGxXBlBGeZGzq0BMGbYlReFlHxMzra9bfDvvY2dXrlY2Lo2jfV91EyoXHAuWT6gJ3_Qpe9DM6zTTFIqOILA38Ii-BiDrXQb3MqEtaagN7704EtvfA1oukU_XG3X_3L66er5m_8C_-RoqA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2711635065</pqid></control><display><type>article</type><title>Metformin, pioglitazone and gout risk</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Liao, Kuan‐Fu ; Hwang, Bing‐Fang ; Kuo, Yu‐Hung ; Liu, Chiu‐Shong ; Lai, Shih‐Wei</creator><creatorcontrib>Liao, Kuan‐Fu ; Hwang, Bing‐Fang ; Kuo, Yu‐Hung ; Liu, Chiu‐Shong ; Lai, Shih‐Wei</creatorcontrib><identifier>ISSN: 1053-8569</identifier><identifier>EISSN: 1099-1557</identifier><identifier>DOI: 10.1002/pds.5516</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Inc</publisher><subject>Antidiabetics ; Gout ; Metformin ; Pioglitazone</subject><ispartof>Pharmacoepidemiology and drug safety, 2022-10, Vol.31 (10), p.1127-1128</ispartof><rights>2022 John Wiley & Sons Ltd.</rights><rights>2022 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3266-524c3b955adb8060f72a47303e01a35d74d559289a61258a7bea00aa8568cc773</citedby><cites>FETCH-LOGICAL-c3266-524c3b955adb8060f72a47303e01a35d74d559289a61258a7bea00aa8568cc773</cites><orcidid>0000-0002-7420-1572</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpds.5516$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpds.5516$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27907,27908,45557,45558</link.rule.ids></links><search><creatorcontrib>Liao, Kuan‐Fu</creatorcontrib><creatorcontrib>Hwang, Bing‐Fang</creatorcontrib><creatorcontrib>Kuo, Yu‐Hung</creatorcontrib><creatorcontrib>Liu, Chiu‐Shong</creatorcontrib><creatorcontrib>Lai, Shih‐Wei</creatorcontrib><title>Metformin, pioglitazone and gout risk</title><title>Pharmacoepidemiology and drug safety</title><subject>Antidiabetics</subject><subject>Gout</subject><subject>Metformin</subject><subject>Pioglitazone</subject><issn>1053-8569</issn><issn>1099-1557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kF1LwzAUhoMoOKfgTyiI4IWdJ0lP0lzK_ISJgnodsjYdmV1TkxaZv97OCYLg1XnhPLy8PIQcU5hQAHbRlnGCSMUOGVFQKqWIcneTkac5CrVPDmJcAgw_lY3I6YPtKh9WrjlPWucXtevMp29sYpoyWfi-S4KLb4dkrzJ1tEc_d0xeb65fpnfp7PH2fno5SwvOhEiRZQWfK0RTznMQUElmMsmBW6CGYymzElGxXBlBGeZGzq0BMGbYlReFlHxMzra9bfDvvY2dXrlY2Lo2jfV91EyoXHAuWT6gJ3_Qpe9DM6zTTFIqOILA38Ii-BiDrXQb3MqEtaagN7704EtvfA1oukU_XG3X_3L66er5m_8C_-RoqA</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Liao, Kuan‐Fu</creator><creator>Hwang, Bing‐Fang</creator><creator>Kuo, Yu‐Hung</creator><creator>Liu, Chiu‐Shong</creator><creator>Lai, Shih‐Wei</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7420-1572</orcidid></search><sort><creationdate>202210</creationdate><title>Metformin, pioglitazone and gout risk</title><author>Liao, Kuan‐Fu ; Hwang, Bing‐Fang ; Kuo, Yu‐Hung ; Liu, Chiu‐Shong ; Lai, Shih‐Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3266-524c3b955adb8060f72a47303e01a35d74d559289a61258a7bea00aa8568cc773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antidiabetics</topic><topic>Gout</topic><topic>Metformin</topic><topic>Pioglitazone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liao, Kuan‐Fu</creatorcontrib><creatorcontrib>Hwang, Bing‐Fang</creatorcontrib><creatorcontrib>Kuo, Yu‐Hung</creatorcontrib><creatorcontrib>Liu, Chiu‐Shong</creatorcontrib><creatorcontrib>Lai, Shih‐Wei</creatorcontrib><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacoepidemiology and drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liao, Kuan‐Fu</au><au>Hwang, Bing‐Fang</au><au>Kuo, Yu‐Hung</au><au>Liu, Chiu‐Shong</au><au>Lai, Shih‐Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metformin, pioglitazone and gout risk</atitle><jtitle>Pharmacoepidemiology and drug safety</jtitle><date>2022-10</date><risdate>2022</risdate><volume>31</volume><issue>10</issue><spage>1127</spage><epage>1128</epage><pages>1127-1128</pages><issn>1053-8569</issn><eissn>1099-1557</eissn><cop>Chichester, UK</cop><pub>John Wiley & Sons, Inc</pub><doi>10.1002/pds.5516</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-7420-1572</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 1053-8569
ispartof	Pharmacoepidemiology and drug safety, 2022-10, Vol.31 (10), p.1127-1128
issn	1053-8569 1099-1557
language	eng
recordid	cdi_proquest_miscellaneous_2698633728
source	Wiley Online Library Journals Frontfile Complete
subjects	Antidiabetics Gout Metformin Pioglitazone
title	Metformin, pioglitazone and gout risk
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A04%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metformin,%20pioglitazone%20and%20gout%20risk&rft.jtitle=Pharmacoepidemiology%20and%20drug%20safety&rft.au=Liao,%20Kuan%E2%80%90Fu&rft.date=2022-10&rft.volume=31&rft.issue=10&rft.spage=1127&rft.epage=1128&rft.pages=1127-1128&rft.issn=1053-8569&rft.eissn=1099-1557&rft_id=info:doi/10.1002/pds.5516&rft_dat=%3Cproquest_cross%3E2711635065%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2711635065&rft_id=info:pmid/&rfr_iscdi=true